Trial Profile
A Pilot Study of MRI [magnetic resonance imaging] and Spectroscopy Imaging Changes With 6-Months of Dutasteride in Patients With Symptomatic Benign Prostatic Hypertrophy and Low-Risk Prostate Cancer on Watchful Waiting or Requiring Neoadjuvant Androgen Suppression Prior to Prostate Brachytherapy.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Dutasteride (Primary)
- Indications Benign prostatic hyperplasia; Prostate cancer
- Focus Therapeutic Use
- 24 Jul 2008 New trial record.